SG133546A1 - New association of a sinus node if current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it - Google Patents

New association of a sinus node if current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it

Info

Publication number
SG133546A1
SG133546A1 SG200608806-6A SG2006088066A SG133546A1 SG 133546 A1 SG133546 A1 SG 133546A1 SG 2006088066 A SG2006088066 A SG 2006088066A SG 133546 A1 SG133546 A1 SG 133546A1
Authority
SG
Singapore
Prior art keywords
inhibitor
pharmaceutical compositions
compositions containing
sinus node
calcium
Prior art date
Application number
SG200608806-6A
Other languages
English (en)
Inventor
Vidal Benatar
Guy Lerebours Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37075950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG133546(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of SG133546A1 publication Critical patent/SG133546A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SG200608806-6A 2005-12-21 2006-12-18 New association of a sinus node if current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it SG133546A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513008A FR2894826B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
SG133546A1 true SG133546A1 (en) 2007-07-30

Family

ID=37075950

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200608806-6A SG133546A1 (en) 2005-12-21 2006-12-18 New association of a sinus node if current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it

Country Status (41)

Country Link
US (3) US20070142356A1 (zh)
EP (1) EP1800683B1 (zh)
JP (2) JP4783275B2 (zh)
KR (1) KR100907584B1 (zh)
CN (1) CN101015556B (zh)
AP (1) AP2208A (zh)
AR (1) AR058575A1 (zh)
AT (1) ATE488239T1 (zh)
AU (1) AU2006252211B2 (zh)
BR (1) BRPI0605516A (zh)
CA (1) CA2571649C (zh)
CO (1) CO5790167A1 (zh)
CR (1) CR8813A (zh)
CY (1) CY1111007T1 (zh)
DE (1) DE602006018247D1 (zh)
DK (1) DK1800683T3 (zh)
EA (1) EA013536B1 (zh)
ES (1) ES2356660T3 (zh)
FR (1) FR2894826B1 (zh)
GE (1) GEP20094603B (zh)
GT (1) GT200600523A (zh)
HK (1) HK1106442A1 (zh)
HR (1) HRP20110028T1 (zh)
IL (1) IL180209A (zh)
JO (1) JO2675B1 (zh)
MA (1) MA28724B1 (zh)
MX (1) MXPA06014884A (zh)
MY (1) MY143563A (zh)
NO (1) NO337509B1 (zh)
NZ (1) NZ552222A (zh)
PE (1) PE20071133A1 (zh)
PL (1) PL1800683T3 (zh)
PT (1) PT1800683E (zh)
RS (1) RS51534B (zh)
SA (1) SA06270482B1 (zh)
SG (1) SG133546A1 (zh)
SI (1) SI1800683T1 (zh)
TW (1) TWI373344B (zh)
UA (1) UA91507C2 (zh)
WO (1) WO2007077329A2 (zh)
ZA (1) ZA200610822B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
FR2920773B1 (fr) 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
WO2009158005A1 (en) * 2008-06-27 2009-12-30 Concert Pharmaceuticals, Inc. Benzazepinone compounds
FR2938194B1 (fr) * 2008-11-07 2012-08-31 Servier Lab Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US20030092745A1 (en) * 2000-02-25 2003-05-15 Pfizer Inc. Combination therapy
EP1426051B1 (en) * 2001-09-11 2008-07-16 Asahi Kasei Pharma Corporation Medicinal composition for prevention of or treatment for cerebrovascular disorder
AR037565A1 (es) * 2001-11-21 2004-11-17 Synthon Bv Formas de sales de amlodipina y procedimientos para prepararlas.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
JO2675B1 (en) 2012-06-17
PE20071133A1 (es) 2007-12-22
DK1800683T3 (da) 2011-03-07
AP2006003858A0 (en) 2006-12-31
FR2894826B1 (fr) 2010-10-22
ATE488239T1 (de) 2010-12-15
IL180209A0 (en) 2008-01-20
JP2011068661A (ja) 2011-04-07
CO5790167A1 (es) 2007-08-31
NZ552222A (en) 2008-05-30
SI1800683T1 (sl) 2011-01-31
AP2208A (en) 2011-02-23
CN101015556B (zh) 2011-08-10
ES2356660T3 (es) 2011-04-12
CA2571649C (fr) 2012-05-22
US20070142356A1 (en) 2007-06-21
PL1800683T3 (pl) 2011-04-29
ZA200610822B (en) 2008-06-25
EP1800683B1 (fr) 2010-11-17
US20090215745A1 (en) 2009-08-27
AU2006252211A1 (en) 2007-07-05
HK1106442A1 (en) 2008-03-14
JP4783275B2 (ja) 2011-09-28
WO2007077329A2 (fr) 2007-07-12
SA06270482B1 (ar) 2011-06-22
TW200744637A (en) 2007-12-16
KR20070066922A (ko) 2007-06-27
HRP20110028T1 (hr) 2011-02-28
RS51534B (en) 2011-06-30
AR058575A1 (es) 2008-02-13
FR2894826A1 (fr) 2007-06-22
UA91507C2 (ru) 2010-08-10
KR100907584B1 (ko) 2009-07-14
EA200602156A1 (ru) 2007-08-31
DE602006018247D1 (de) 2010-12-30
MY143563A (en) 2011-05-31
TWI373344B (en) 2012-10-01
IL180209A (en) 2015-05-31
CY1111007T1 (el) 2015-06-11
PT1800683E (pt) 2010-12-17
MA28724B1 (fr) 2007-07-02
NO20065903L (no) 2007-06-22
WO2007077329A3 (fr) 2007-09-07
EA013536B1 (ru) 2010-06-30
BRPI0605516A (pt) 2007-10-16
JP2007169284A (ja) 2007-07-05
GT200600523A (es) 2007-07-25
CA2571649A1 (fr) 2007-06-21
GEP20094603B (en) 2009-02-10
CR8813A (es) 2007-06-06
EP1800683A1 (fr) 2007-06-27
AU2006252211B2 (en) 2012-05-17
US20110230466A1 (en) 2011-09-22
NO337509B1 (no) 2016-05-02
CN101015556A (zh) 2007-08-15
MXPA06014884A (es) 2009-02-11

Similar Documents

Publication Publication Date Title
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
IS7735A (is) Bensódíasepín afleiður og lyfjasamsetningar sem innihalda þær.
MX2008002492A (es) Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
SG133546A1 (en) New association of a sinus node if current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
ZA200604874B (en) Pharmaceutical compositions
ATE350461T1 (de) Riechstoffzusammensetzung
EP2125831A4 (en) ISOFLAVONOID OXAZINYL COMPOUNDS, MEDICAMENTS AND USE
EA200600953A1 (ru) Дозированные формы торсемида пролонгированного высвобождения
DE602004027808D1 (de) Tablette enthaltend fluvastatin und calciumcarmellose
GEP20084546B (en) Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent
CU23733A3 (es) Composición que comprende un inhibidor selectivo de la corriente sinusal if y de un inhibidor cálcico
UY30022A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor de la enzima de conversion y las composiciones farmaceuticas que la contienen
NO20085189L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamid-benzotaizepiner, fremstilling og anvendelse derav sammensetninger inneholdende samme
MY135184A (en) New salt of perindopril and pharmaceutical compositions containing it
TW200505868A (en) New synerglstic combinations